Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.115
-0.155 (-4.74%)
At close: Mar 5, 2026, 4:00 PM EST
3.080
-0.040 (-1.28%)
Pre-market: Mar 6, 2026, 7:30 AM EST
Evotec SE Employees
Evotec SE had 4,740 employees as of December 31, 2024. The number of employees decreased by 321 or -6.34% compared to the previous year.
Employees
4,740
Change (1Y)
-321
Growth (1Y)
-6.34%
Revenue / Employee
$185,338
Profits / Employee
-$38,958
Market Cap
1.12B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,379 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,012 |
| ANI Pharmaceuticals | 970 |
| Pacira BioSciences | 790 |
| Cronos Group | 459 |
| Harrow | 382 |
EVO News
- 2 months ago - Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Accesswire
- 2 months ago - Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Accesswire
- 3 months ago - Evotec: How Low A Company May Go While Still Being Attractive - Seeking Alpha
- 3 months ago - Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz - Accesswire
- 3 months ago - Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome - Accesswire
- 4 months ago - Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership - Accesswire
- 4 months ago - Evotec SE (EVO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities - Accesswire